A Sampling of Clips for 
July 13, 2006

* UCSD faculty and staff may obtain a copy of an article by e-mailing the University Communications Office

Study Shows Risks
and Benefits from Lilly Drug
Reuters, July 12 - Doctors had thought that Eli Lilly and Co.'s osteoporosis drug Evista, known generically as raloxifene and used to treat the bone-thinning disease osteoporosis, might help prevent heart problems because it lowers cholesterol and improves other indicators of heart-disease risk. But after giving either the drug or a placebo to the women for an average of five and a half years, the research team led by Elizabeth Barrett-Connor of UCSD found that the medicine had no effect on the incidence of heart attacks, heart failure or death from heart-related causes. More

Rampart's Redemption
Rooted in Complex Forces
Los Angeles Times, July 13 - Big, bad Rampart is no more. Home to MacArthur Park, once home to the city's densest murder cluster, the Los Angeles police division has undergone a transformation so broad that for the last two years, homicides per capita have fallen to the citywide average. (Quotes David Pedersen, UCSD anthropologist and El Salvador expert) More

Harvard Stem Cells Favored
Over Those Produced with U.S. Funds
Bloomberg, July 13 - The Bush administration's restrictions on embryonic stem-cell research are driving scientists to seek out cells from privately funded programs. Embryonic stem cells created at Harvard University are being used three times more often than those from the National Stem Cell Bank, the largest source of cells that can be studied using U.S. research grants. (Quotes Larry Goldstein, Professor of Cellular and Molecular Medicine at UCSD) More

Research Building Dedicated
San Diego Union-Tribune, July 13 - The La Jolla Institute for Allergy & Immunology and the drug research firm Gemini Science dedicated a $43 million building yesterday in their bid to study further infectious diseases and disorders of the immune system.  The four-story structure is situated at UCSD's Science Research Park, just east of the John & Rebecca Moores Cancer Center. More

Similar story in:
KPBS

Mechanics of Atherosclerosis
Medical Research News, July 12 - Atherosclerosis, the collection of deposits such as cholesterol along artery walls, accounts for nearly 75 percent of deaths from cardiovascular disease. Most drugs to treat atherosclerosis influence the levels of cholesterol and other lipids in the blood, but UCSD researchers suspect that understanding the role of mechanical forces acting on blood vessel cells may help to design better approaches to treatment. More